Typewriter raises $56M for jumping gene technology and in vivo CAR-T therapies
- Posted on September 2, 2026
- By Google News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Typewriter raises $56M for jumping gene technology and in vivo CAR-T therapies
Typewriter Therapeutics raises $56M Series A to build RNA-based jumping-gene therapies for in vivo CAR-T and genetic liver disease.
